Glanbia Nutritionals Market Insights and Bioactives Solutions

Picture of Patrick Wang

Patrick Wang

Expert of Peptides | Ask me anything about Peptides | Sales Manager at AHB Lab
Cover

Table of Contents

In the dynamic world of nutrition and wellness, staying ahead of the curve is crucial. This was the central theme of the seminar hosted by Glanbia at BIO Asia-Taiwan 2023, where Mayuresh Bedekar, Director of Product Strategy-Bioactives from California, USA, shared Glanbia Nutritionals Market Insights and innovative bioactive solutions.

Glanbia Nutritionals Market Insights

 

Glanbia Nutritionals: A Global Leader in Performance Nutrition

Glanbia Nutritionals, a global leader in performance nutrition, is renowned for its commitment to innovation and quality. The company offers a wide range of nutrition solutions, including bioactive ingredients, cheese solutions, custom premix, flavors by Foodarom®, micronutrients, plant-based proteins, and functionally optimized nutrient technologies.

 

Glanbia Nutritionals Market Insights of The Asia-Pacific Sports Nutrition Market: A Growing Giant

The seminar delved deep into the current trends in the Asia-Pacific sports nutrition market, which is witnessing a growth rate of 10.9% from 2022 to 2027. The total retail sales in 2022 for sports, active & healthy lifestyle nutrition performance in the AsPac region amounted to $8.1 billion, with sports protein products accounting for $3.2 billion. This growth is a testament to the increasing awareness and demand for sports and performance nutrition products in the region.

 

Personalization: The Future of Nutrition

One of the key takeaways from the seminar was the growing trend of personalization in nutrition. The mantra of a ‘healthy mind in a healthy body’ is gaining traction, especially among next-generation athletes, including video gamers. This demographic is increasingly seeking personalized nutrition solutions to enhance their physical and mental performance.

 

Immunity: A Top Consumer Concern

Across the globe, boosting immunity has emerged as a top concern for consumers, especially those aged between 25-34. This age group is increasingly turning to supplementation as a means to enhance their immunity, reflecting a shift in consumer behavior towards preventive healthcare.

 

Bioferrin®: Glanbia’s Answer to Immunity Concerns

For instance, Bioferrin®, a lactoferrin-based product, is designed to support immune health, a need that is more relevant now than ever before. This innovative product is a testament to Glanbia’s commitment to addressing the evolving needs of consumers and staying ahead of market trends.

 

The Future of Nutrition: Transdermal Nutrition

The seminar didn’t just focus on the present; it also shed light on the future of nutrition. One of the emerging trends is the rise of transdermal nutrition – a method of delivering nutrients through the skin. While oral intake continues to be popular, transdermal nutrition is gaining momentum.

 

AHB Lab’s ICPPX: A Pioneer in Transdermal Nutrition

This is where AHB Lab comes into the picture. As a pioneer in the field, AHB Lab has developed ICPPX, a type 2 collagen peptide designed specifically for individuals suffering from conditions such as osteoarthritis, degenerative arthritis, tendon fasciitis, ligamentitis, muscle ache, and sprain. It also aids in tissue repair and reducing lactic acid buildup.

Product that's made of ICPPX

 

The Consumer Landscape in Asia

The seminar also discussed the consumer landscape in Asia, with the population divided into four categories based on lifestyle and activity level: Sports Performance (8%), Inactive Lifestyle (32%), Active Lifestyle (35%), and Healthy Lifestyle (25%). This segmentation provides valuable insights into the diverse needs and preferences of consumers in the region, enabling companies like Glanbia and AHB Lab to tailor their products and services accordingly.

 

Sports Nutrition Launches: A Global Perspective

The seminar also revealed that sports nutrition launches are growing in each region, with Asia showing a growth of 24%, Europe 19%, North America 10%, Australasia 14%, and Latin America 21%. These figures underscore the global demand for sports nutrition products and the opportunities for companies like Glanbia and AHB Lab to expand their market presence.

 

The Role of Glanbia in the Global Nutrition Landscape

Glanbia’s role in the global nutrition landscape is significant. With its extensive portfolio of products and solutions, the company is well-positioned to cater to the evolving needs of consumers worldwide. The company’s commitment to research and development is evident in its innovative products like Bioferrin®, which addresses the growing consumer concern for immune health.

 

The Evolution of Nutrition: A Look at the Future

The seminar also highlighted the evolution of nutrition, with a focus on the rise of transdermal nutrition. This method of delivering nutrients through the skin is gaining momentum, and companies like AHB Lab are at the forefront of this trend. AHB Lab’s ICPPX, a type 2 collagen peptide, is a pioneering product in the field of transdermal nutrition.

 

Conclusion

The seminar by Glanbia was an enlightening journey through the current market trends and the future of nutrition. It underscored the importance of innovation and personalization in meeting the evolving needs of consumers. As we move forward, it’s clear that companies like Glanbia and AHB Lab, with their commitment to innovation and quality, will continue to lead the way in the nutrition and wellness industry.

Last but not least thanks Mayuresh Bedekar for sharing Glanbia Nutritionals Market Insights!

Leave a Reply

Your email address will not be published. Required fields are marked *

公司最新訊息

你的消炎藥只是在「關掉煙霧探測器」?從源頭阻斷慢性發炎的胜肽科學

為什麼你的疲倦與疼痛總是反覆發作? 你是不是經常覺得關節痠痛、莫名疲倦,或者有各種過敏和腸胃問題,卻始終找不出確切原因 ? 在現代高壓與快節奏的生活中,許多人都在尋求這些亞健康狀態的解藥。事實上,現代人90%的慢性病,其實都來自同一個源頭:你體內有一把撲不滅的「無名火」,醫學上稱之為「慢性發炎」 。 當面臨這些不適,多數人的第一反應是服用非類固醇消炎藥(NSAIDs)或類固醇。然而,這些傳統藥物往往只能提供短暫的舒緩,一旦停藥,症狀便會捲土重來。這不禁讓我們反思:我們是否只在處理表面症狀,而忽略了真正的問題根源?   傳統消炎藥的盲點與機制 要理解傳統藥物的局限性,我們必須先了解發炎的運作機制。當身體受到外界刺激時,免疫系統中的「巨噬細胞」會釋放 TNF-α 和 IL-1β 等發炎細胞因子 。這本是身體為了防禦而響起的警報器,但當免疫系統失衡,這些發炎因子便會失控形成「細胞因子風暴」,開始無差別攻擊正常細胞、黏膜和關節,甚至破壞 DNA 。 傳統的西藥如 NSAIDs 是如何運作的呢?它們主要的作用機制是抑制下游的 COX-1 或 COX-2 酵素 。 為了讓大家更直觀地理解,我們可以比較一下這兩種機制的差異:

Read More
公司最新訊息

止痛藥的隱形代價:淨火肽如何透過「8小時降解」機制重塑無毒抗炎新標準?

引言 在現代高壓的生活節奏中,面對關節痠痛或慢性疲勞,多數人的第一反應往往是去藥房購買非類固醇消炎止痛藥,或是服用醫生開立的類固醇 。當藥效發揮,疼痛的警報聲停止,我們便誤以為身體恢復了健康 。 然而,你吞下的那顆止痛藥,在讓你感覺不到痛之後,究竟去了哪裡? 這是一個多數消費者忽略,而品牌研發端必須正視的痛點。傳統藥物在體內的作用機制,實際上只是粗暴地抑制了下游的 COX 酵素 。這就像是一群莽漢直接砸爛了火災警報器,卻對真正引發火災的源頭無能為力 。更嚴重的是,這些無法被身體完全辨識與利用的化學合成物,在完成掩蓋任務後並不會憑空消失,而是轉化為化學廢棄物 。 這些殘留物迫使肝臟超負荷運作以進行代謝,同時也讓腎臟拼命處理排毒 。由於 COX 酵素被過度抑制,人體保護胃壁的機制隨之停擺,最終導致腸胃黏膜逐漸受到破壞 。這不是真正的治療,而是一場用內臟健康換取短暫不痛的恐怖交易 。身為保健或保養品牌的決策者,我們必須思考:除了這種「拆東牆補西牆」的化學療法,我們能否為市場提供一種更安全、無毒的解答?   核心機制深潛 為了解決傳統消炎藥物的瓶頸,富比積生物科技(AHB Lab)突破傳統藥理學限制,研發出名為「淨火肽 Healtide®」的第三代生物合成定序胜肽 。這項技術透過「生物黑客」的思維,重新定義了抗炎機制的標準。   1.

Read More
公司最新訊息

你體內的「無名火」正在搞破壞!一招從源頭撲滅慢性發炎(淨火肽 Healtide® 機理大解密)

為什麼吃了消炎藥,身體的「火」還是滅不掉? 你是否經常遇到這樣的客戶反饋:消費者面對關節痠痛、過敏、腸胃不適或皮膚慢性暗沉,長期服用非類固醇消炎藥(NSAIDs)或塗抹類固醇,卻總是反覆發作、治標不治本 ?   現代醫學與功能生物學證實:90% 的慢性疾病與老化瓶頸,核心源頭都來自體內撲不滅的「慢性發炎」。 傳統生技產品或化學藥物的開發邏輯,大多著眼於抑制下游的 COX-1 或 COX-2 酵素 。用一個心智模型(Mental Model)來比喻:這就像火災發生時,你只是跑去「關掉煙霧探測器」,卻根本沒有沒收那個正在不斷點火的「打火機」! 長期下來,不僅無法根除發炎,化學藥物更可能增加肝腎與腸胃道的代謝負擔 。 市場正在尋找一種更高訊噪比、能「從源頭斷火」且安全無副作用的革命性生物素材。這正是富比積生物科技(AHB Lab)董事長莊國昇博士與研發團隊,成功推出第三代生物合成定序胜肽——淨火肽(Healtide®)的契機 。   淨火肽(Healtide®)的源頭阻斷機制 當人體受到刺激時,免疫系統的「巨噬細胞」會釋放 TNF-α(腫瘤壞死因子)與 IL-1β 等發炎細胞因子 。一旦失控,就會引發無差別攻擊正常組織的「細胞因子風暴」

Read More